Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Ecotoxicol Environ Saf ; 130: 37-42, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27062344

ABSTRACT

Environmental contamination of mercury (Hg) has caused public health concerns with focuses on the neurotoxic substance methylmercury, due to its bioaccumulation and biomagnification in food chains. The goals of the present study were to examine: (i) the transformation of methylmercury, thimerosal, phenylmercuric acetate and mercuric chloride by cultures of Pseudomonas putida V1, (ii) the presence of the genes merA and merB in P. putida V1, and (iii) the degradation pathways of methylmercury by P. putida V1. Strain V1 cultures readily degraded methylmercury, thimerosal, phenylmercury acetate, and reduced mercuric chloride into gaseous Hg(0). However, the Hg transformation in LB broth by P. putida V1 was influenced by the type of Hg compounds. The merA gene was detected in P. putida V1, on the other hand, the merB gene was not detected. The sequencing of this gene, showed high similarity (100%) to the mercuric reductase gene of other Pseudomonas spp. Furthermore, tests using radioactive (14)C-methylmercury indicated an uncommon release of (14)CO2 concomitant with the production of Hg(0). The results of the present work suggest that P. putida V1 has the potential to remove methylmercury from contaminated sites. More studies are warranted to determine the mechanism of removal of methylmercury by P. putida V1.


Subject(s)
Methylmercury Compounds/metabolism , Pseudomonas putida/metabolism , Bacterial Proteins/genetics , Environmental Pollutants/metabolism , Environmental Restoration and Remediation , Lyases/genetics , Mercuric Chloride/metabolism , Oxidoreductases/genetics , Phenylmercuric Acetate/metabolism , Pseudomonas putida/genetics , Thimerosal/metabolism
2.
Exp Cell Res ; 314(16): 2907-18, 2008 Oct 01.
Article in English | MEDLINE | ID: mdl-18687326

ABSTRACT

Soluble isoforms of the epidermal growth factor receptor (sEGFR) previously have been identified in the conditioned culture media (CCM) of the vulvar adenocarcinoma cell line, A431 and within exosomes of the keratinocyte cell line HaCaT. Here, we report that the extracellular domain (ECD) of EGFR is shed from the cell surface of human carcinoma cell lines that express 7x10(5) receptors/cell or more. We purified this proteolytic isoform of EGFR (PI-sEGFR) from the CCM of MDA-MB-468 breast cancer cells. The amino acid sequence of PI-sEGFR was determined by reverse-phase HPLC nano-electrospray tandem mass spectrometry of peptides generated by trypsin, chymotrypsin or GluC digestion. The PI-sEGFR protein is identical in amino acid sequence to the EGFR ECD. The release of PI-sEGFR from MDA-MB-468 cells is enhanced by phorbol 12-myristate 13-acetate, heat-inactivated fetal bovine serum, pervanadate, and EGFR ligands (i.e., EGF and TGF-alpha). In addition, 4-aminophenylmercuric acetate, an activator of metalloproteases, increased PI-sEGFR levels in the CCM of MDA-MB-468 cells. Inhibitors of metalloproteases decreased the constitutive shedding of EGFR while the PMA-induced shedding was inhibited by metalloprotease inhibitors, by the two serine protease inhibitors leupeptin and 3,4-dichloroisocoumarin (DCI), and by the aspartyl inhibitor pepstatin. These results suggest that PI-sEGFR arises by proteolytic cleavage of EGFR via a mechanism that is regulated by both PKC- and phosphorylation-dependent pathways. Our results further suggest that when proteolytic shedding of EGFR does occur, it is correlated with a highly malignant phenotype.


Subject(s)
ErbB Receptors/metabolism , Neoplasms/metabolism , Protein Isoforms/metabolism , Amino Acid Sequence , Animals , Cattle , Cell Line, Tumor , Enzyme Activation , Epidermal Growth Factor/metabolism , ErbB Receptors/chemistry , ErbB Receptors/genetics , Humans , Molecular Sequence Data , Peptides/chemistry , Peptides/genetics , Peptides/metabolism , Phenylmercuric Acetate/analogs & derivatives , Phenylmercuric Acetate/metabolism , Protease Inhibitors/metabolism , Protein Isoforms/genetics , Protein Kinase C/metabolism , Protein Structure, Tertiary , Sequence Alignment , Spectrometry, Mass, Electrospray Ionization , Tetradecanoylphorbol Acetate/metabolism , Transforming Growth Factor alpha/metabolism , Vanadates/metabolism
3.
Plant Biotechnol J ; 5(2): 254-62, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17309680

ABSTRACT

Eastern cottonwood (Populus deltoides Bartr. ex Marsh.) trees were engineered to express merA (mercuric ion reductase) and merB (organomercury lyase) transgenes in order to be used for the phytoremediation of mercury-contaminated soils. Earlier studies with Arabidopsis thaliana and Nicotiana tabacum showed that this gene combination resulted in more efficient detoxification of organomercurial compounds than did merB alone, but neither species is optimal for long-term field applications. Leaf discs from in vitro-grown merA, nptII (neomycin phosphotransferase) transgenic cottonwood plantlets were inoculated with Agrobacterium tumefaciens strain C58 carrying the merB and hygromycin resistance (hptII) genes. Polymerase chain reaction of shoots regenerated from the leaf discs under selection indicated an overall transformation frequency of 20%. Western blotting of leaves showed that MerA and MerB proteins were produced. In vitro-grown merA/merB plants were highly resistant to phenylmercuric acetate, and detoxified organic mercury compounds two to three times more rapidly than did controls, as shown by mercury volatilization assay. This indicates that these cottonwood trees are reasonable candidates for the remediation of organomercury-contaminated sites.


Subject(s)
Lyases/genetics , Oxidoreductases/genetics , Phenylmercuric Acetate/metabolism , Populus/genetics , Biodegradation, Environmental , Blotting, Western , Cinnamates/pharmacology , Drug Resistance , Hygromycin B/analogs & derivatives , Hygromycin B/pharmacology , Organomercury Compounds/metabolism , Phenylmercuric Acetate/pharmacology , Plant Leaves/genetics , Plant Leaves/metabolism , Plant Shoots/genetics , Plant Shoots/growth & development , Plants, Genetically Modified , Polymerase Chain Reaction , Populus/enzymology , Populus/growth & development , Rhizobium/genetics , Transformation, Genetic , Transgenes
4.
Environ Geochem Health ; 28(1-2): 103-10, 2006.
Article in English | MEDLINE | ID: mdl-16528587

ABSTRACT

Perennial monoculture forming grasses are very important natural remediators of pollutants. Their genetic improvement is an important task because introduction of key transgenes can dramatically improve their remediation potential. Transfer of key genes for mercury phytoremediation into the salt marsh cordgrass (Spartina alterniflora) is reported here. S. alterniflora plays an important role in the salt marsh by cycling of elements, both nutrients and pollutants, protects the coastline from erosion, is a keystone species in the salt marsh supporting a large food web, which in turn supports a significant segment of economy, including tourism, has an impact on cloud formation and consequently on global weather, and is thus an ecologically important species relevant for our life-support systems. Embryogenic callus of S. alterniflora was co-inoculated with a pair of Agrobacterium strains LBA4404 carrying the organomercurial lyase (merB) and mercuric reductase (merA) genes, respectively, in order to co-introduce both the merA and the merB genes. Seven stable geneticin resistant lines were recovered. The presence of merA and merB genes was verified by PCR and Southern blotting. All but one transgenic lines contained both the merA and the merB sequences proving that co-introduction into Spartina of two genes from separate Agrobacterium strains is feasible and frequent, although the overall frequency of transformation is low. Northern blotting showed differences in relative expression of the two transgenes among individual transformants. The steady-state RNA levels appeared to correlate with the phenotype. Line #7 showed the highest resistance to HgCl(2) (up to 500 microM), whereas line #3 was the most resistant to phenylmercuric acetate (PMA). Wild-type (WT) callus is sensitive to PMA at 50 microM and to HgCl(2) at 225 microM.


Subject(s)
Plants, Genetically Modified , Poaceae/physiology , Rhizobium/physiology , Biodegradation, Environmental , Cell Culture Techniques , Climate , Genetic Engineering , Lyases/genetics , Lyases/metabolism , Mercuric Chloride/metabolism , Mercuric Chloride/toxicity , Oxidoreductases/genetics , Oxidoreductases/metabolism , Phenotype , Phenylmercuric Acetate/metabolism , Phenylmercuric Acetate/toxicity , Poaceae/genetics , Poaceae/growth & development , Polymerase Chain Reaction , Rhizobium/genetics , Rhizobium/growth & development
5.
Eur J Biochem ; 271(12): 2539-47, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15182369

ABSTRACT

Numerous transmembrane proteins, including the blood pressure regulating angiotensin converting enzyme (ACE) and the Alzheimer's disease amyloid precursor protein (APP), are proteolytically shed from the plasma membrane by metalloproteases. We have used an antisense oligonucleotide (ASO) approach to delineate the role of ADAM10 and tumour necrosis factor-alpha converting enzyme (TACE; ADAM17) in the ectodomain shedding of ACE and APP from human SH-SY5Y cells. Although the ADAM10 ASO and TACE ASO significantly reduced (> 81%) their respective mRNA levels and reduced the alpha-secretase shedding of APP by 60% and 30%, respectively, neither ASO reduced the shedding of ACE. The mercurial compound 4-aminophenylmercuric acetate (APMA) stimulated the shedding of ACE but not of APP. The APMA-stimulated secretase cleaved ACE at the same Arg-Ser bond in the juxtamembrane stalk as the constitutive secretase but was more sensitive to inhibition by a hydroxamate-based compound. The APMA-activated shedding of ACE was not reduced by the ADAM10 or TACE ASOs. These results indicate that neither ADAM10 nor TACE are involved in the shedding of ACE and that APMA, which activates a distinct ACE secretase, is the first pharmacological agent to distinguish between the shedding of ACE and APP.


Subject(s)
Amyloid beta-Protein Precursor/metabolism , Endopeptidases/metabolism , Metalloendopeptidases/metabolism , Peptidyl-Dipeptidase A/metabolism , Phenylmercuric Acetate/analogs & derivatives , ADAM Proteins , ADAM17 Protein , Amyloid Precursor Protein Secretases , Amyloid beta-Protein Precursor/chemistry , Animals , Aspartic Acid Endopeptidases , Carbachol/metabolism , Cell Line , Cricetinae , Endopeptidases/genetics , Enzyme Activation , Humans , Metalloendopeptidases/genetics , Oligonucleotides, Antisense/genetics , Oligonucleotides, Antisense/metabolism , Peptidyl-Dipeptidase A/chemistry , Phenylmercuric Acetate/metabolism , Protein Structure, Tertiary , RNA, Messenger/metabolism
6.
Gene ; 301(1-2): 13-20, 2002 Nov 13.
Article in English | MEDLINE | ID: mdl-12490319

ABSTRACT

The broad-spectrum mercury resistance transposon, TnMERI1, of Bacillus megaterium strain MB1, contains three proposed operator/promoter (O/P) transcriptional start sites and two regulatory genes (merR1 and merR2). A series of luciferase (lux)-based transcriptional fusion plasmids were studied in Escherichia coli to show that both merR1 and merR2 gene products repressed transcription from O/PmerB3, O/PmerR1, and O/PmerR2 under uninduced conditions. Derepression occurred when the merR1 gene was present and Hg(2+) functioned as an inducer. In the presence of organomercurial compounds, basal transcription of merB3 was needed to produce inorganic Hg(2+) as the inducer of expression regulated by MerR1 at O/PmerB3. The presence of merR2 repressed transcription from all three O/Pmer sites under both non-induced conditions and when inorganic Hg(2+) or organomercurials were added. These results show that MerR1 functions as a repressor in the absence of Hg(2+) and as an activator in the presence of Hg(2+), while MerR2 functions as a repressor.


Subject(s)
Bacterial Proteins/genetics , DNA Transposable Elements/genetics , DNA-Binding Proteins/genetics , Bacillus megaterium/genetics , Bacterial Proteins/metabolism , DNA-Binding Proteins/metabolism , Drug Resistance, Microbial/genetics , Escherichia coli/drug effects , Escherichia coli/genetics , Gene Expression Regulation , Luciferases/genetics , Luciferases/metabolism , Lyases/metabolism , Mercury/metabolism , Mercury/pharmacology , Phenylmercuric Acetate/metabolism , Phenylmercuric Acetate/pharmacology , Plasmids/genetics , Protein Isoforms/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
7.
J Nihon Univ Sch Dent ; 39(4): 182-90, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9476431

ABSTRACT

A useful gelatinolytic enzyme assay for fibroblasts, utilizing a novel sample preparation method for collagenase with dithiothreitol (DTT) treatment to inactivate endogenous collagenase inhibitors, was developed using soluble fluorescein isothiocyanate (FITC)-labeled gelatin. The substrate, gelatin was prepared by heating commercially available FITC-labeled type I collagen. The denatured collagen was cleaved with purified trypsin and partially purified fibroblast gelatinase, and the digested FITC-fragments were measured fluorometrically. The intensity of the fluorescence was in proportion to the reaction time and enzyme concentration. Both enzyme activities were measurable within the nanogram range of enzyme preparations. The enzyme activity was detected after 4-aminophenylmercuric acetate (APMA) treatment which was completely inhibited by metalloproteinase inhibitors, but not by serine- and cysteine-proteinases' inhibitors. Conditioned media of human periodontal ligament fibroblasts (PLF) and gingival fibroblasts (GF) were separately treated with DTT prior to the enzyme assay, and then the assay was performed in the presence of APMA. The enzyme activities of PLF and GF were 106- and 55-fold higher than those of the conventional gelatinase assay which was carried out without DTT treatment. This assay method allowed the measurement of gelatinolytic enzyme activity when tissue inhibitors of metalloproteinases were present in the fibroblast culture medium.


Subject(s)
Fibroblasts/enzymology , Gelatinases/analysis , Biological Assay , Cells, Cultured , Collagen/metabolism , Collagenases/metabolism , Culture Media, Conditioned , Cysteine Proteinase Inhibitors/metabolism , Dithiothreitol/metabolism , Enzyme Inhibitors/metabolism , Fluorescein-5-isothiocyanate , Fluorescent Dyes , Fluorometry , Gelatin/metabolism , Gingiva/cytology , Humans , Matrix Metalloproteinase Inhibitors , Metalloendopeptidases/antagonists & inhibitors , Periodontal Ligament/cytology , Phenylmercuric Acetate/analogs & derivatives , Phenylmercuric Acetate/metabolism , Serine Proteinase Inhibitors/metabolism , Sulfhydryl Reagents/metabolism , Tissue Inhibitor of Metalloproteinases/metabolism , Trypsin/metabolism
10.
Indian J Exp Biol ; 29(12): 1147-9, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1816104

ABSTRACT

A broad-spectrum Hg-resistant strain of B. pasteurii DR2 utilized phenylmercuric acetate (PMA) as sole source of carbon. This bacterial strain contained a constitutive organomercurial lyase which specifically degraded PMA but not other organo-mercurials. This PMA-lyase activity was also stimulated to different extents when this bacterial strain was grown in presence of different organic compounds as sole source of carbon.


Subject(s)
Bacillus/enzymology , Lyases/metabolism , Mercury/pharmacology , Phenylmercuric Acetate/metabolism , Bacillus/drug effects , Drug Resistance, Microbial
11.
J Biol Chem ; 266(29): 19342-50, 1991 Oct 15.
Article in English | MEDLINE | ID: mdl-1918050

ABSTRACT

Hydrogen peroxide reacts with two-electron reduced glutathione reductase (GR EH2 species) to give the native oxidized enzyme (E) without detectable intermediates. Prior alkylation of the EH2 interchange thiol with iodoacetamide, however, dramatically changes both the course and overall rate of the peroxide reaction. This oxidation, monitored spectrally, is characterized by an intermediate (EHRint) with enhanced long wavelength absorbance extending to 800 nm. This species decays in a second peroxide-dependent phase to an enzyme form (EHRox) easily distinguished from E. Quenching experiments with catalase allow the isolation of a stable mixture consisting of 36% monoalkylated GR (EHR), 60% EHRint, and 4% EHRox; NADPH titration and anaerobic dithiothreitol addition lead to quantitative reduction of EHRint to EHR, and there is an increase in thiol titer of 0.8-SH/FAD on NADPH reduction. Of the four titratable thiols present in EHR, 2.7 are lost on oxidation to EHRox and 0.7-0.8 mol of cysteic acid/FAD is formed. On the basis of these and other observations, we conclude that alkylation of the EH2 interchange thiol, which blocks disulfide formation, allows peroxide reaction at the remaining charge-transfer thiol to proceed via a stabilized cysteine-sulfenic acid intermediate (EHRint), which undergoes further oxidation to the corresponding cysteic acid (EHRox).


Subject(s)
Glutathione Reductase/metabolism , Hydrogen Peroxide/chemistry , Saccharomyces cerevisiae/enzymology , Alkylation , Binding Sites , Chromatography, Gel , Dithiothreitol/metabolism , Electrophoresis, Polyacrylamide Gel , Iodoacetamide/chemistry , Methyl Methanesulfonate/analogs & derivatives , Methyl Methanesulfonate/metabolism , NADP/metabolism , Oxidation-Reduction , Phenylmercuric Acetate/metabolism
12.
Toxicology ; 54(3): 323-33, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2539660

ABSTRACT

The efficiency of the sodium salt of 2,3-dimercaptopropanesulfonic acid (DMPS) and meso-dimercaptosuccinic acid (DMSA) to mobilize mercury from tissues has been assessed in rats pretreated with different doses of HgCl2, phenylmercury acetate or exposed to different concentrations of mercury vapors. These pretreatments increase the mercury concentration in the kidney and to a lower extent in the liver. Only exposure to metallic mercury vapor leads to mercury accumulation in the brain. Both chelators mobilize mercury stored in the kidney and the amount of metal excreted in urine following a single administration of DMSA is a good indicator of the renal burden of mercury. The rate of removal is greater after DMPS administration than after DMSA but repeated administration of either agents eventually leads to the same total amount of mercury mobilized from the kidney. The loss of mercury from the liver can be slightly accelerated by repeated administration of the chelators. However, the chelators are inefficient in removing mercury from the brain.


Subject(s)
Dimercaprol/analogs & derivatives , Mercuric Chloride/administration & dosage , Mercury/administration & dosage , Phenylmercuric Acetate/administration & dosage , Phenylmercury Compounds/administration & dosage , Succimer/pharmacology , Sulfhydryl Compounds/pharmacology , Unithiol/pharmacology , Administration, Inhalation , Administration, Oral , Animals , Brain/metabolism , Injections, Intraperitoneal , Injections, Intravenous , Kidney/metabolism , Liver/metabolism , Male , Mercuric Chloride/metabolism , Mercury/metabolism , Mercury/urine , Phenylmercuric Acetate/metabolism , Rats , Rats, Inbred Strains , Succimer/urine , Unithiol/urine
13.
Membr Biochem ; 6(4): 269-89, 1986.
Article in English | MEDLINE | ID: mdl-3574139

ABSTRACT

Intrinsic tryptophan fluorescence in red cell ghost membranes labeled with N-ethylmaleimide (N-EM) is quenched in a dose-dependent manner by the organic mercurial p-chloromercuribenzene sulfonate (p-CMBS). Fluorescence lifetime analysis shows that quenching occurs by a static mechanism. Binding of p-CMBS occurs by a rapid (less than 5 s) biomolecular association (dissociation constant K1 = 1.8 mM) followed by a slower unimolecular transition with forward rate constant k2 = 0.015 s-1 and reverse rate constant k-2 = 0.0054 s-1. Analysis of the temperature dependence of k2 gives delta H = 6.5 kcal/mol and delta S = -21 eu. The mercurial compounds p-chloromercuribenzoic acid, p-aminophenylmercuric acetate, and mercuric chloride quench red cell tryptophan fluorescence by the same mechanism as p-CMBS does; the measured k2 value was the same for each compound, whereas K1 varied. p-CMBS also quenches the tryptophan fluorescence in vesicles reconstituted with purified band 3, the red cell anion exchange protein, in a manner similar to that in ghost membranes. These experiments define a mercurial binding site on band 3 in ghosts treated with N-EM and establish the binding mechanism to this site. The characteristics of this p-CMBS binding site on band 3 differ significantly from those of the p-CMBS binding site involved in red cell water and urea transport inhibition.


Subject(s)
Chloromercuribenzoates/pharmacology , Erythrocyte Membrane/drug effects , Anion Exchange Protein 1, Erythrocyte/metabolism , Biological Transport/drug effects , Body Water/metabolism , Chloromercuribenzoates/metabolism , Depression, Chemical , Dose-Response Relationship, Drug , Erythrocyte Membrane/metabolism , Ethylmaleimide , Fluorescence , Humans , Kinetics , Phenylmercuric Acetate/analogs & derivatives , Phenylmercuric Acetate/metabolism , Phenylmercuric Acetate/pharmacology , Protein Binding , Tryptophan , Urea/metabolism , p-Chloromercuribenzoic Acid
14.
Can J Microbiol ; 31(3): 276-81, 1985 Mar.
Article in English | MEDLINE | ID: mdl-4005712

ABSTRACT

A methodology for determining the minimum inhibitory concentration of inorganic and organomercurial compounds for obligate anaerobic bacteria is described. A wide variation in the susceptibility of anaerobic clinical and sewage isolates was observed. Isolates of Bacteroides ruminicola and Clostridium perfringens resistant to mercury were examined for their plasmid content and ability to demonstrate inducible resistance. None of the resistant anaerobes contained any plasmids, while resistant facultative isolates from the same source contained several plasmids. In 24 h, resistant strains of clostridia and Bacteroides volatilized 20 and 43% of the 203Hg2+ added to cultures, while Escherichia coli R100 and a sewage isolate of Enterobacter cloacae volatilized 63 and 27%, respectively, of the added 203Hg2+. Attempts to induce mercury resistance in the aerobic isolates were successful, but no induction was seen in the anaerobes. Thus, mercury resistance in these anaerobic isolates was neither inducible nor plasmid mediated.


Subject(s)
Bacteria, Anaerobic/metabolism , Ethylmercury Compounds/toxicity , Mercuric Chloride/metabolism , Organomercury Compounds/metabolism , Thimerosal/toxicity , Anti-Bacterial Agents/pharmacology , Bacteria, Anaerobic/drug effects , Bacteria, Anaerobic/genetics , DNA, Bacterial/genetics , Drug Resistance, Microbial , Mercuric Chloride/pharmacology , Organomercury Compounds/pharmacology , Phenylmercuric Acetate/metabolism , Phenylmercuric Acetate/pharmacology , Sewage , Thimerosal/metabolism , Thimerosal/pharmacology
15.
Vet Hum Toxicol ; 21(5): 321-7, 1979 Oct.
Article in English | MEDLINE | ID: mdl-516360

ABSTRACT

Phenylmercuric acetate (PMA) was administered orally to a horse over a period of 27 weeks (190 days) at a dose rate of 0.4 mg Hg/kg per day. The effects produced were consistent with those of chronic inorganic mercury intoxication. The clinical features included masseter muscle atrophy, difficulty in prehension and mastication, malodorous breath, reduced appetite and weight loss, and reflected significant pathological changes involving the buccal, mandibular and dental tissues. Renal dysfunction was evident terminally and there was degeration and necrosis of the proximal tubular epithelium. Necrotic and mineralized foci were found in facial and masticatory msucles, splenic trabecuale and the myocardium. The central nervous system and the intestinal tract were unaffected. The approximate mean plasma inorganic mercury concentration was 500 ng/ml whereas organic mercury levels in blood were much lower. The renal cortex had the highest inorganic mercury content, three times greater than in the liver and cecum, while organic mercury was highest in those tissues and absent from the kidney. The difference in the effects produced in this horse as compared to those in a horse receiving mercuric chloride at the same mercury dose rate, could be attributed to the more rapid and complete absorption of PMA from the gastrointestinal tract.


Subject(s)
Horse Diseases/chemically induced , Phenylmercuric Acetate/toxicity , Phenylmercury Compounds/toxicity , Animals , Chronic Disease , Horse Diseases/metabolism , Horse Diseases/pathology , Horses , Male , Mercury/metabolism , Phenylmercuric Acetate/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...